Since the early 2000s, when fluorescent proteins (FP) were functionally expressed in heterologous cells, they found a wealth of applications in molecular biology from live cell imaging to measuring proteinprotein interactions. Recently, a novel approach was developed to use FPs for labeling peptide toxins from scorpion venom, which are indispensable tools to study structure and pharmacology of potassium voltage-gated (Kv) channels [1] . Production of genetically encoded fluorescent protein-scorpion toxin chimeras (FP-Tx) has certain advantages over synthetic labeling of peptides, namely, the targeted incorporation of FP into the N-or C-terminus of a polypeptide chain, and a simple and reproducible purification procedure, which is characterized by high yield and homogeneity of recombinant FP-Tx.
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Here we used enhanced green fluorescent protein (eGFP) to tag peptide toxin hongotoxin 1 (HgTx1), which is a high-affinity blocker of a number of related Kv1 channels (Kv1.1-Kv1.3). The gene encoding eGFP-HgTx1 was cloned into NcoI/HindIII sites of pET23d vector (Novagen) and expressed in E. coli Rosetta-gami pLysS. His6-tagged eGFP-HgTx1 protein was affinity-purified from bacteria with a high yield (about 80 mg per 1 l of culture). Absorption spectrum of obtained FP-Tx was similar to that of eGFP. To study affinity of eGFP-HgTx1 to Kv1.1-and Kv1.3-binding sites, we used confocal fluorescent microscopy and bioengineered analytical systems, which are based on receptor KcsA-Kv1.x (x=1, 3) chimeric proteins embedded in the plasma membrane of E.coli spheroplasts [2, 3] . eGFP-HgTx1 was shown to bind to KcsA-Kv1.1-and KcsA-Kv1.3-presenting spheroplasts and easily displaced from the binding sites with non-labeled HgTx1 used in several-fold excess (Fig. 1) . To determine affinity of eGFP-HgTx1 to the target receptors, saturation binding curves were measured ( Fig.  1 B) , and dissociation constants (Kd) of ligand-receptor complexes were estimated: 3.2±1.4 nM for KcsA-Kv1.1 and 1.1±0.2 nM for KcsA-Kv1.3. The Kd values correlate qualitatively with those obtained for 125 I-HgTX1-A19Y/Y37F in a radioligand assay (0.4 nM for KcsA-Kv1.1 and 0.03 nM for KcsA-Kv1.3) [4] .
We carried out detailed studies to characterize ability of different Kv1-channel blockers belonging to α-KTx family of scorpion venom -derived peptides to displace eGFP-HgTx1 from the complexes with KcsA-Kv1.3 in a competitive binding assay (Fig.1 C) . For this, peptide toxins HgTx1, agitoxin 2 (AgTx2), kaliotoxin (KTX), and charybdotoxin (ChTx), which were obtained in a recombinant form according to the previously developed technique [5] , were used. All these peptides exhibited high affinity to the receptor KcsA-Kv1.3 protein, and apparent dissociation constants (Ki) were determined to be: 200 pM for HgTx1, 245 pM for AgTx2, 115 pM for ChTx, and 20 pM for KTX. These Ki values are similar to the known ones estimated for the binding of these toxins to the eukaryotic Kv1. 
